Market Research Logo

Global Nasal Spray Devices Market Forecast 2019-2027

Global Nasal Spray Devices Market Forecast 2019-2027

KEY FINDINGS

Patients suffering from diseases such as allergic and non-allergic rhinitis, CNS disorders, etc. incline towards the adoption of nasal sprays as these pose certain advantages over other forms of drug delivery systems. Some of these advantages are good patient compliance, convenience, controlled delivery, and others. The global nasal spray devices market deals with the adoption of such devices that are used for the purpose of delivering drugs through the nose. They contain therapeutically active ingredients in the form of a solution, suspension and others.

The global nasal spray devices market is expected to generate revenue of $24,264 million by 2027 and is estimated to grow at a CAGR of 6.78% between 2019 and 2027.

MARKET INSIGHTS

The prevalence of chronic obstructive pulmonary diseases (COPD) among respiratory disease can be observed by the growing number of patients with breathing difficulties. Hence, the increasing prevalence of respiratory diseases worldwide is creating lucrative adoption base for nasal spray devices, thereby fueling the market growth. The rising adoption of generics drugs due to their lower prescription costs is also a major influencing factor for market growth in the global arena.

The severe regulations are hindering the nasal spray devices market. The various incidences of product recall reported by FDA or companies itself act as a restraining factor for global nasal spray devices market over the forecast period.

REGIONAL INSIGHTS

The global nasal spray devices market has been geographically segmented by four major regions, which include North America, Europe, Asia Pacific and the Rest of World.

The nasal spray devices market in North America will be dominating the global market with respect to the share by 2027 since there are possibilities of increased numbers of government investments in developing nasal spray products along with the high incidence of asthma and other respiratory diseases. North America constituted a share of approximately xx% in 2018.

COMPETITIVE ANALYSIS

GlaxoSmithKline, Cipla, Adapt Pharma, Inc. (acquired by Emergent BioSolutions), Sun Pharmaceuticals Industries, Ltd., Mylan NV, Pfizer, Inc., Beximco Pharmaceuticals, Apotex, Merck & Co., Inc., Sanofi-Aventis S.A., Becton Dickinson and Company, Sandoz International GmbH (subsidiary of Novartis AG), Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC and Allergan Inc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Decongestion Nasal Spray Holds The Largest Market Share In Terms Of Product
3.2.2. Over-the-counter Prescription Is Anticipated To Grow Significantly
3.2.3. Antihistamine Is The Fastest Growing Therapeutics
3.2.4. Nasal Congestion Is The Majorly Used Application Of Nasal Spray Devices
3.2.5. Home Care Setting Is The Fastest Growing End-user
4. Market Determinants
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Surge In Incidence Of Respiratory Diseases
4.2.2. Low Cost Of Generic Prescription Drugs
4.3. Market Restraints
4.3.1. Stringent Regulation
4.3.2. Rising Incidences Of Product Recall
4.4. Market Opportunities
4.4.1. Rising Adoption Of Generic Drugs
4.4.2. Growing Demand Of Nasal Drugs In Pharmaceutical Market
4.5. Market Challenges
4.5.1. Patent Expiration
5. Market By Product
5.1. Decongestion Nasal Spray
5.2. Saltwater Solution/ Saline Nasal Spray
5.3. Steroid Nasal Spray
6. Market By Prescription
6.1. Over-the-counter
6.2. Prescribed
7. Market By Therapeutic
7.1. Antihistamine
7.2. Anticholinergic
7.3. Mast Cell Inhibitor
7.4. Nasal Steroids
8. Market By Application
8.1. Allergic And Non-allergic Rhinitis
8.2. Cns Disorders
8.3. Nasal Congestion
8.4. Vaccination
8.5. Other Application
9. Market By End-user
9.1. Asc/Clinics
9.2. Home Care Setting
9.3. Hospital
9.4. Pharmacy
9.5. Other End-user
10. Key Analytics
10.1. Porter’s Five Forces Model
10.1.1. Threat Of New Entrants
10.1.2. Threat Of Substitute
10.1.3. Bargaining Power Of Buyers
10.1.4. Bargaining Power Of Suppliers
10.1.5. Threat Of Competitive Rivalry
10.2. Key Buying Criteria
10.3. Supply Chain Analysis
10.4. Regulatory Framework
10.5. Parent Market Analysis
10.6. Opportunity Matrix
11. Geographical Analysis
11.1. North America
11.1.1. The United States
11.1.2. Canada
11.2. Europe
11.2.1. The United Kingdom
11.2.2. France
11.2.3. Germany
11.2.4. Spain
11.2.5. Italy
11.2.6. Rest Of Europe
11.3. Asia Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest Of Asia Pacific
11.4. Rest Of World
11.4.1. Latin America
11.4.2. Middle East And Africa
12. Competitive Landscape
12.1. Market Share Analysis
12.2. Company Profiles
12.2.1. Adapt Pharma, Inc. (Acquired By Emergent Biosolutions)
12.2.1.1. Company Overview
12.2.1.2. Product Launch
12.2.1.3. Strategic Initiatives
12.2.2. Allergan Inc.
12.2.2.1. Company Overview
12.2.2.2. Product & Services
12.2.2.3. Scot Analysis
12.2.2.4. Strategic Initiatives
12.2.3. Apotex
12.2.3.1. Company Overview
12.2.3.2. Product Portfolio
12.2.3.3. Strategic Initiatives
12.2.4. Becton Dickinson And Company
12.2.4.1. Company Overview
12.2.4.2. Product Portfolio
12.2.4.3. Scot Analysis
12.2.4.4. Strategic Initiatives
12.2.5. Beximco Pharmaceuticals
12.2.5.1. Company Overview
12.2.5.2. Product Launch
12.2.5.3. Strategic Initiatives
12.2.6. Cipla
12.2.6.1. Company Overview
12.2.6.2. Product Portfolio
12.2.6.3. Scot Analysis
12.2.6.4. Strategic Initiatives
12.2.7. Glaxosmithkline
12.2.7.1. Company Overview
12.2.7.2. Product Portfolio
12.2.7.3. Scot Analysis
12.2.7.4. Strategic Initiatives
12.2.8. Hikma Pharmaceuticals Plc
12.2.8.1. Company Overview
12.2.8.2. Product Portfolio
12.2.8.3. Strategic Initiatives
12.2.9. Merck & Co., Inc.
12.2.9.1. Company Profiles
12.2.9.2. Product Portfolio
12.2.9.3. Scot Analysis
12.2.9.4. Strategic Initiatives
12.2.10. Mylan Nv
12.2.10.1. Company Overview
12.2.10.2. Product Portfolio
12.2.10.3. Strategic Initiatives
12.2.11. Pfizer, Inc.
12.2.11.1. Company Profiles
12.2.11.2. Product Portfolio
12.2.11.3. Scot Analysis
12.2.11.4. Strategic Initiatives
12.2.12. Sandoz International Gmbh (Subsidiary Of Novartis Ag)
12.2.12.1. Company Overview
12.2.12.2. Product Portfolio
12.2.12.3. Strategic Initiatives
12.2.13. Sanofi-aventis S.A.
12.2.13.1. Company Overview
12.2.13.2. Product Portfolio
12.2.13.3. Scot Analysis
12.2.13.4. Strategic Initiatives
12.2.14. Sun Pharmaceuticals Industries, Ltd.
12.2.14.1. Company Overview
12.2.14.2. Product Portfolio
12.2.14.3. Scot Analysis
12.2.14.4. Strategic Initiative
12.2.15. Teva Pharmaceutical Industries Ltd.
12.2.15.1. Company Overview
12.2.15.2. Product Portfolio
12.2.15.3. Strategic Initiatives
Table List
Table 1 Global Nasal Spray Devices Market By Region 2019-2027 ($ Million)
Table 2 Global Nasal Spray Devices Market By Product 2019-2027 ($ Million)
Table 3 Global Decongestion Nasal Spray Market By Region 2019-2027 ($ Million)
Table 4 Global Salt Water Solution/ Saline Nasal Spray Market By Region 2019-2027 ($ Million)
Table 5 Global Steroid Nasal Spray Market By Region 2019-2027 ($ Million)
Table 6 Global Nasal Spray Devices Market By Prescription 2019-2027 ($ Million)
Table 7 Global Over-the-counter Market By Region 2019-2027 ($ Million)
Table 8 Global Prescribed Market By Region 2019-2027 ($ Million)
Table 9 Global Nasal Spray Devices Market By Therapeutic 2019-2027 ($ Million)
Table 10 Global Antihistamine Market By Region 2019-2027 ($ Million)
Table 11 Global Anticholinergic Market By Region 2019-2027 ($ Million)
Table 12 Global Mast Cell Inhibitor Market By Region 2019-2027 ($ Million)
Table 13 Global Nasal Steroids Market By Region 2019-2027 ($ Million)
Table 14 Global Nasal Spray Devices Market By Application 2019-2027 ($ Million)
Table 15 Global Allergic And Non-allergic Rhinitis Market By Region 2019-2027 ($ Million)
Table 16 Global Cns Disorders Market By Region 2019-2027 ($ Million)
Table 17 Global Nasal Congestion Market By Region 2019-2027 ($ Million)
Table 18 Global Vaccination Market By Region 2019-2027 ($ Million)
Table 19 Global Other Application Market By Region 2019-2027 ($ Million)
Table 20 Global Nasal Spray Devices Market By End-user 2019-2027 ($ Million)
Table 21 Global Asc/Clinics Market By Region 2019-2027 ($ Million)
Table 22 Global Home Care Setting Market By Region 2019-2027 ($ Million)
Table 23 Global Hospital Market By Region 2019-2027 ($ Million)
Table 24 Global Pharmacy Market By Region 2019-2027 ($ Million)
Table 25 Global Other End-user Market By Region 2019-2027 ($ Million)
Table 26 Global Nasal Spray Devices Market By Region 2019-2027 ($ Million)
Table 27 North America Nasal Spray Devices Market By Country 2019-2027 ($ Million)
Table 28 Europe Nasal Spray Devices Market By Country 2019-2027 ($ Million)
Table 29 Asia Pacific Nasal Spray Devices Market By Country 2019-2027 ($ Million)
Table 30 Rest Of World Nasal Spray Devices Market By Region 2019-2027 ($ Million)
Figures List
Figure 1 Global Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 2 Deaths Caused Due To Various Respiratory Diseases 2012-2016
Figure 3 Global Nasal Spray Devices Market Share By Product 2018 & 2027 (%)
Figure 4 Global Nasal Spray Devices Market By Decongestion Nasal Spray 2019-2027 ($ Million)
Figure 5 Global Nasal Spray Devices Market By Salt Water Solution/ Saline Nasal Spray 2019-2027 ($ Million)
Figure 6 Global Nasal Spray Devices Market By Steroid Nasal Spray 2019-2027 ($ Million)
Figure 7 Global Nasal Spray Devices Market Share By Prescription 2018 & 2027 (%)
Figure 8 Global Nasal Spray Devices Market By Over-the-counter 2019-2027 ($ Million)
Figure 9 Global Nasal Spray Devices Market By Prescribed 2019-2027 ($ Million)
Figure 10 Global Nasal Spray Devices Market Share By Therapeutic 2018 & 2027 (%)
Figure 11 Global Nasal Spray Devices Market By Antihistamine 2019-2027 ($ Million)
Figure 12 Global Nasal Spray Devices Market By Anticholinergic 2019-2027 ($ Million)
Figure 13 Global Nasal Spray Devices Market By Mast Cell Inhibitor 2019-2027 ($ Million)
Figure 14 Global Nasal Spray Devices Market By Nasal Steroids 2019-2027 ($ Million)
Figure 15 Global Nasal Spray Devices Market Share By Application 2018 & 2027 (%)
Figure 16 Global Nasal Spray Devices Market By Allergic And Non-allergic Rhinitis 2019-2027 ($ Million)
Figure 17 Global Nasal Spray Devices Market By Cns Disorders 2019-2027 ($ Million)
Figure 18 Global Nasal Spray Devices Market By Nasal Congestion 2019-2027 ($ Million)
Figure 19 Global Nasal Spray Devices Market By Vaccination 2019-2027 ($ Million)
Figure 20 Global Nasal Spray Devices Market By Other Application 2019-2027 ($ Million)
Figure 21 Global Nasal Spray Devices Market Share By End-user 2018 & 2027 (%)
Figure 22 Global Nasal Spray Devices Market By Asc/Clinics 2019-2027 ($ Million)
Figure 23 Global Nasal Spray Devices Market By Home Care Setting 2019-2027 ($ Million)
Figure 24 Global Nasal Spray Devices Market By Hospital 2019-2027 ($ Million)
Figure 25 Global Nasal Spray Devices Market By Pharmacy 2019-2027 ($ Million)
Figure 26 Global Nasal Spray Devices Market By Other End-user 2019-2027 ($ Million)
Figure 27 Porter’s Five Force Model
Figure 28 Key Buying Criteria
Figure 29 Global Nasal Spray Devices Supply Chain Analysis
Figure 30 Global Nasal Spray Devices Market Regional Outlook 2018 & 2027 (%)
Figure 31 The United States Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 32 Canada Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 33 The United Kingdom Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 34 France Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 35 Germany Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 36 Spain Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 37 Italy Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 38 Rest Of Europe Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 39 China Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 40 India Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 41 Japan Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 42 Australia Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 43 South Korea Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 44 Rest Of Asia Pacific Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 45 Latin America Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 46 Middle East And Africa Nasal Spray Devices Market 2019-2027 ($ Million)
Figure 47 Nasal Spray Devices Company Market Share 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook